|
|
Volumn 83, Issue 2, 2002, Pages 171-173
|
|
Hypertrophic cardiomyopathy with massive hypertrophy, amiodarone treatment and high defibrillation threshold at cardioverter-defibrillator implant [3]
a
|
|
Author keywords
Amiodarone; Cardioverter defibrillator; Hypertrophic cardiomyopathy; Sudden death
|
|
Indexed keywords
AMIODARONE;
SOTALOL;
ADULT;
CASE REPORT;
CLINICAL FEATURE;
DEFIBRILLATION;
DEFIBRILLATOR;
DRUG WITHDRAWAL;
HEART VENTRICLE HYPERTROPHY;
HUMAN;
HYPERTROPHIC CARDIOMYOPATHY;
LETTER;
LONG TERM CARE;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
DIZZINESS;
DRUG SUBSTITUTION;
ELECTRODE IMPLANT;
HEART LEFT VENTRICLE HYPERTROPHY;
HEART VENTRICLE FIBRILLATION;
HEART VENTRICLE PACING;
HEART VENTRICLE TACHYCARDIA;
HEART VENTRICLE WALL;
HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY;
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR;
SHOCK;
TREATMENT DURATION;
ADULT;
AMIODARONE;
CARDIOMYOPATHY, HYPERTROPHIC;
COMBINED MODALITY THERAPY;
DEFIBRILLATORS, IMPLANTABLE;
DIFFERENTIAL THRESHOLD;
ECHOCARDIOGRAPHY, DOPPLER;
FOLLOW-UP STUDIES;
HUMANS;
HYPERTROPHY, LEFT VENTRICULAR;
LONG-TERM CARE;
MALE;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
SOTALOL;
|
|
EID: 0036243001
PISSN: 01675273
EISSN: None
Source Type: Journal
DOI: 10.1016/S0167-5273(02)00036-0 Document Type: Letter |
|
Times cited : (9)
|
|
References (7)
|
